acetylcysteine has been researched along with raloxifene hydrochloride in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Baillie, TA; Blizzard, TA; Cai, X; Chen, Q; DiNinno, FP; Doss, GA; Evans, DC; Hammond, ML; Ngui, JS; Stearns, RA; Tang, W; Wang, RW | 1 |
Kaufmann, Y; Klimberg, VS; Luo, S; Todorova, VK | 1 |
Aurrekoetxea, I; del Agua, AR; Elorriaga, MA; Guéraud, F; Rodriguez, F; Ruiz-Larrea, MB; Ruiz-Sanz, JI | 1 |
Aguado, T; Botella, LM; Del Río, M; Ferrer-Mayorga, G; García, A; García, M; Martínez-Santamaría, L; Sánchez-Puelles, JM | 1 |
5 other study(ies) available for acetylcysteine and raloxifene hydrochloride
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Cytochrome P450 3A4-mediated bioactivation of raloxifene: irreversible enzyme inhibition and thiol adduct formation.
Topics: Acetylcysteine; Animals; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Female; Gas Chromatography-Mass Spectrometry; Glutathione; Hepatocytes; Humans; Magnetic Resonance Spectroscopy; Male; Microsomes, Liver; Oxidation-Reduction; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Sulfhydryl Compounds | 2002 |
Tamoxifen and raloxifene suppress the proliferation of estrogen receptor-negative cells through inhibition of glutamine uptake.
Topics: Acetylcysteine; Amino Acid Transport System ASC; Antioxidants; Apoptosis; Biological Transport; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Fragmentation; Dose-Response Relationship, Drug; Estradiol; Female; Gene Expression; Glutamine; Glutathione; Humans; Minor Histocompatibility Antigens; Oxidative Stress; Raloxifene Hydrochloride; Receptors, Estrogen; Tamoxifen | 2011 |
Involvement of G-463A MPO gene polymorphism in the response of postmenopausal women to hormone therapy.
Topics: Acetylcysteine; alpha-Tocopherol; Antioxidants; Estradiol; Female; Hormone Replacement Therapy; Humans; Intercellular Adhesion Molecule-1; Lipids; Malondialdehyde; Middle Aged; Peroxidase; Polymorphism, Genetic; Postmenopause; Progesterone; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Uric Acid | 2011 |
Raloxifene and n-Acetylcysteine Ameliorate TGF-Signalling in Fibroblasts from Patients with Recessive Dominant Epidermolysis Bullosa.
Topics: Acetylcysteine; Activin Receptors, Type II; Antioxidants; Case-Control Studies; Collagen Type VII; Drug Repositioning; Endoglin; Epidermolysis Bullosa; Estrogen Antagonists; Extracellular Matrix Proteins; Fibroblasts; Fibrosis; Gene Expression Regulation; Humans; Inheritance Patterns; Primary Cell Culture; Raloxifene Hydrochloride; Receptor, Transforming Growth Factor-beta Type I; Severity of Illness Index; Signal Transduction; Skin; Smad Proteins; Transforming Growth Factor beta1 | 2020 |